BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
2.740
0.00 (0.00%)
May 14, 2025, 10:13 AM - Market open
BioCardia Employees
As of December 31, 2024, BioCardia had 20 total employees, including 16 full-time and 4 part-time employees. The number of employees did not change compared to the previous year.
Employees
20
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$2,900
Profits / Employee
-$397,300
Market Cap
13.94M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
BCDA News
- 4 days ago - BioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, 2025 - GlobeNewsWire
- 4 weeks ago - BioCardia Initiates Patient Enrollment at Emory University School of Medicine for Ongoing CardiAMP HF II Pivotal Study - GlobeNewsWire
- 6 weeks ago - BioCardia, Inc. (BCDA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - BioCardia's Conference Call Today, Monday, March 31, 2025 to be Held at 4:30PM EDT Time Today - GlobeNewsWire
- 6 weeks ago - BioCardia Reports 2024 Business Highlights and Financial Results - GlobeNewsWire
- 7 weeks ago - BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025 - GlobeNewsWire
- 2 months ago - BioCardia Announces Japanese Patent for Helix™ Biotherapeutic Delivery System - GlobeNewsWire
- 2 months ago - BioCardia Announces Primary Outcome Measures Data Freeze in CardiAMP Heart Failure Trial for Presentation at the American College of Cardiology 2025 Scientific Sessions - GlobeNewsWire